Salesforce Stock Continues to Struggle to Gain Traction. Is It Time to Fish for the Stock or Cut Bait?

Salesforce's Q1 revenue rose 13% year over year to $11.13 billion, ahead of both guidance and the $11.05 billion consensus, while adjusted EPS climbed 37% to $3.88 versus $3.12 expected. Agentforce ARR surged 205% to $1.2 billion, and the company raised full-year EPS guidance to $14.06-$14.12 from $13.11-$13.19 while authorizing a $25 billion accelerated buyback. Despite the strong results, the stock remains under pressure this year and is highlighted as inexpensive at 3.5x forward sales and 13x forward earnings.

Analysis

The market is treating CRM like a late-cycle SaaS multiple compression story, but the more interesting read is that management is using buybacks and AI monetization to re-anchor the equity as a cash-return + platform upgrade compounder. That matters because the incremental AI narrative can lift sentiment without needing near-term saturation-level revenue contribution; even modest attach rates across a huge installed base can meaningfully expand ARR over 12-24 months if seat expansion and workflow automation monetize before competitors can replicate the data layer.

The second-order winner is less NVDA and more the enterprise data/control-plane ecosystem. If CRM’s AI stack starts to look like the default system of record for agent workflows, the competitive pressure shifts toward point solutions and adjacent SaaS vendors that rely on standalone workflow ownership; that is a headwind for smaller horizontal software names with weaker data moats. Informatica’s value proposition also improves in a world where clean master data becomes the gating factor for agent adoption, but there is execution risk around integration timing and whether customers actually consolidate spend or merely pilot more tools.

The main risk is that the current rerating thesis can stall if AI revenue remains “important but not yet material” for another few quarters while core growth decelerates in the weakest segments. In that scenario, the stock stays trapped in a valuation box despite optically cheap earnings because investors will continue to discount the quality of buyback-driven EPS growth versus true operating leverage. Time horizon matters: near-term upside is a sentiment/flow trade over 1-3 months; the fundamental bull case needs 2-4 quarters of evidence that AI is reducing churn, lifting net retention, or driving higher deal sizes.

The contrarian view is that the market may be underestimating how quickly CRM can re-rate if macro SaaS selling pressure fades and the company simply delivers low-teens growth with aggressive capital returns. But it may also be overestimating how much of the AI narrative is already in the stock: if the platform becomes a strategic moat rather than a direct revenue engine, the upside is slower and more durable than traders expect, which argues for buying weakness rather than chasing a breakout.

Key Decisions for Investors

• Long CRM on a 3-6 month horizon on weakness below ~13-14x forward EPS; risk/reward favors a rerating toward mid-teens multiples if buybacks support EPS and AI attach rates keep compounding.
• Pair trade: long CRM / short a basket of slower-growth SaaS names with weaker data moats over the next 1-2 quarters; thesis is CRM benefits from capital returns and platform concentration while smaller peers face AI commoditization pressure.
• Buy CRM Jan-2027 calls or call spreads if implied vol remains subdued; structure for a 12-18 month AI monetization re-rate with downside capped by the balance-sheet-backed buyback program.
• Use INFA as a relative-value hedge: long CRM vs short INFA only if the market begins pricing integration risk more aggressively; otherwise INFA can act as a complementary beneficiary of master-data demand, so avoid an outright short on first read.
• Do not chase here after a post-earnings pop; wait for a 5-8% pullback or a broader SaaS risk-off tape to enter, because the stock’s near-term driver is multiple expansion, not a step-change in fundamentals.